AI-assembled from public SEC filings

Warehouse and discount retail peer review

Descriptive comparison assembled from public SEC filings and verified companyfacts.

Descriptive comparison — not investment advice. This feature-specific review is assembled from a frozen evidence pack of public SEC filing quotes and verified SEC companyfacts numbers. It is descriptive only and makes no judgment about which company is better. It is not a rating, recommendation, endorsement, forecast, or investment advice. Figures are as of their cited filing dates. See Disclaimer.

Governing statutes (not legal advice)

Descriptive law cross-reference — not legal advice. grepcent publishes a curated industry-to-statute association only. This is not legal advice. It does not interpret statutes, assess company conduct, or mirror statute text. Deep links go to neochart.

Statutes grepcent curates as governing this industry, deep-linked to neochart's official text. Case-citation counts are shown as an importance signal, not the selection criterion. Not legal advice. Citing cases are shown as a case-citation in-degree importance signal, not an endorsement.

12 U.S.C. § 24: §24. Corporate powers of associations (299 citing cases; source neochart)
- 12 U.S.C. § 21: cited together in 74 opinions in the neochart library
- 12 U.S.C. § 1: cited together in 35 opinions in the neochart library
- 12 U.S.C. § 92: cited together in 32 opinions in the neochart library
12 U.S.C. § 1821: § 1821. Insurance Funds (1,399 citing cases; source neochart)
- 12 U.S.C. § 1823: cited together in 308 opinions in the neochart library
- 12 U.S.C. § 1819: cited together in 228 opinions in the neochart library
- 12 U.S.C. § 1811: cited together in 107 opinions in the neochart library
12 U.S.C. § 1841: § 1841. Definitions (150 citing cases; source neochart)
- 12 U.S.C. § 1842: cited together in 57 opinions in the neochart library
- 12 U.S.C. § 1848: cited together in 45 opinions in the neochart library
- 12 U.S.C. § 1843: cited together in 44 opinions in the neochart library

Methodology

Mechanical U.S. megabank cluster: companies in the existing grepcent universe with SEC SIC 6021 National Commercial Banks and latest reported total assets above $1 trillion. These are exactly the four banks held out of the regional-banks cluster by its large-regional asset band, so this cluster gives them a home rather than leaving them excluded into nothing.

The cluster is selected mechanically from public SEC SIC 6021 companies already present in grepcent's processed universe, filtered to latest reported total assets above $1 trillion using the same SEC companyfacts figures shown on grepcent company pages. The next largest SIC 6021 bank sits near $669 billion in assets, well inside the regional band, so the threshold separates the two clusters cleanly. The review publishes no proprietary index-membership labels.

Provenance

Pack hash: 9f8767dff473ba5d86868d533aa7846876b35ccc64aeee4e1d329e0dc2f1920a. Generated: 2026-07-23.

Verified Quantitative Matrix

Numbers are templated from frozen SEC companyfacts-derived facts already verified by grepcent. Fiscal periods and filing dates are shown in each cell; comparability markers use day-level period ends and reported XBRL source concepts.

Metric	JPM	BAC	C	WFC
Revenue Mixed reporting concepts: us-gaap:Revenues, us-gaap:RevenuesNetOfInterestExpense. Ticker concepts: BAC -> us-gaap:Revenues; C -> us-gaap:Revenues; JPM -> us-gaap:Revenues; WFC -> us-gaap:RevenuesNetOfInterestExpense.	182,447,000,000 FY 2025; period end 2025-12-31; filed 2026-02-13; reporting currency USD source Day-level period offset: 0d vs row reference 2025-12-31; aligned.	113,097,000,000 FY 2025; period end 2025-12-31; filed 2026-02-25; reporting currency USD source Day-level period offset: 0d vs row reference 2025-12-31; aligned.	85,225,000,000 FY 2025; period end 2025-12-31; filed 2026-02-20; reporting currency USD source Day-level period offset: 0d vs row reference 2025-12-31; aligned.	83,699,000,000 FY 2025; period end 2025-12-31; filed 2026-02-24; reporting currency USD source Day-level period offset: 0d vs row reference 2025-12-31; aligned.
Net margin Mixed reporting concepts: us-gaap:NetIncomeLoss, us-gaap:Revenues, us-gaap:RevenuesNetOfInterestExpense. Ticker concepts: BAC -> us-gaap:NetIncomeLoss + us-gaap:Revenues; C -> us-gaap:NetIncomeLoss + us-gaap:Revenues; JPM -> us-gaap:NetIncomeLoss + us-gaap:Revenues; WFC -> us-gaap:NetIncomeLoss + us-gaap:RevenuesNetOfInterestExpense.	31.27% FY 2025; period end 2025-12-31; filed 2026-02-13 source Day-level period offset: 0d vs row reference 2025-12-31; aligned.	26.98% FY 2025; period end 2025-12-31; filed 2026-02-25 source Day-level period offset: 0d vs row reference 2025-12-31; aligned.	16.79% FY 2025; period end 2025-12-31; filed 2026-02-20 source Day-level period offset: 0d vs row reference 2025-12-31; aligned.	25.49% FY 2025; period end 2025-12-31; filed 2026-02-24 source Day-level period offset: 0d vs row reference 2025-12-31; aligned.
Dividends paid Mixed reporting concepts: us-gaap:PaymentsOfDividends, us-gaap:PaymentsOfDividendsCommonStock. Ticker concepts: C -> us-gaap:PaymentsOfDividends; JPM -> us-gaap:PaymentsOfDividends; WFC -> us-gaap:PaymentsOfDividendsCommonStock.	16,625,000,000 FY 2025; period end 2025-12-31; filed 2026-02-13; reporting currency USD source Day-level period offset: 0d vs row reference 2025-12-31; aligned.	Not available.	5,372,000,000 FY 2025; period end 2025-12-31; filed 2026-02-20; reporting currency USD source Day-level period offset: 0d vs row reference 2025-12-31; aligned.	5,434,000,000 FY 2025; period end 2025-12-31; filed 2026-02-24; reporting currency USD source Day-level period offset: 0d vs row reference 2025-12-31; aligned.
Share buybacks	31,591,000,000 FY 2025; period end 2025-12-31; filed 2026-02-13; reporting currency USD source Day-level period offset: 0d vs row reference 2025-12-31; aligned.	21,433,000,000 FY 2025; period end 2025-12-31; filed 2026-02-25; reporting currency USD source Day-level period offset: 0d vs row reference 2025-12-31; aligned.	13,250,000,000 FY 2025; period end 2025-12-31; filed 2026-02-20; reporting currency USD source Day-level period offset: 0d vs row reference 2025-12-31; aligned.	17,516,000,000 FY 2025; period end 2025-12-31; filed 2026-02-24; reporting currency USD source Day-level period offset: 0d vs row reference 2025-12-31; aligned.
Assets	4,424,900,000,000 FY 2025; period end 2025-12-31; filed 2026-02-13; reporting currency USD source Day-level period offset: 0d vs row reference 2025-12-31; aligned.	3,411,738,000,000 FY 2025; period end 2025-12-31; filed 2026-02-25; reporting currency USD source Day-level period offset: 0d vs row reference 2025-12-31; aligned.	2,657,202,000,000 FY 2025; period end 2025-12-31; filed 2026-02-20; reporting currency USD source Day-level period offset: 0d vs row reference 2025-12-31; aligned.	2,148,631,000,000 FY 2025; period end 2025-12-31; filed 2026-02-24; reporting currency USD source Day-level period offset: 0d vs row reference 2025-12-31; aligned.
Liabilities / equity	11.21 FY 2025; period end 2025-12-31; filed 2026-02-13 source Day-level period offset: 0d vs row reference 2025-12-31; aligned.	10.25 FY 2025; period end 2025-12-31; filed 2026-02-25 source Day-level period offset: 0d vs row reference 2025-12-31; aligned.	11.51 FY 2025; period end 2025-12-31; filed 2026-02-20 source Day-level period offset: 0d vs row reference 2025-12-31; aligned.	10.85 FY 2025; period end 2025-12-31; filed 2026-02-24 source Day-level period offset: 0d vs row reference 2025-12-31; aligned.

Code-computed comparisons

Reported net margin range: range endpoints are C (16.79%) and JPM (31.27%). Calendar period: 2025-Q4. Computed from facts NUM_C_NET_MARGIN_FY2025 and NUM_JPM_NET_MARGIN_FY2025; comparability: period aligned; reference 2025-12-31; offsets BAC 0d aligned, C 0d aligned, JPM 0d aligned, WFC 0d aligned; tags mixed; concepts us-gaap:NetIncomeLoss, us-gaap:Revenues, us-gaap:RevenuesNetOfInterestExpense; concept mapping BAC -> us-gaap:NetIncomeLoss + us-gaap:Revenues; C -> us-gaap:NetIncomeLoss + us-gaap:Revenues; JPM -> us-gaap:NetIncomeLoss + us-gaap:Revenues; WFC -> us-gaap:NetIncomeLoss + us-gaap:RevenuesNetOfInterestExpense; no authored numeric comparison.
Latest reported revenue range: range endpoints are WFC (83,699,000,000) and JPM (182,447,000,000). Calendar period: 2025-Q4. Computed from facts NUM_WFC_REVENUE_FY2025 and NUM_JPM_REVENUE_FY2025; comparability: period aligned; reference 2025-12-31; offsets BAC 0d aligned, C 0d aligned, JPM 0d aligned, WFC 0d aligned; tags mixed; concepts us-gaap:Revenues, us-gaap:RevenuesNetOfInterestExpense; concept mapping BAC -> us-gaap:Revenues; C -> us-gaap:Revenues; JPM -> us-gaap:Revenues; WFC -> us-gaap:RevenuesNetOfInterestExpense; no authored numeric comparison.

Market-risk companion: risk and factor comparison from lmfin. It is descriptive and separate from the SEC fundamentals review.

Provenance

Facts: 25. Claims shown: 0. Claims withheld: 0. Cells withheld: 24.

Withheld quantitative rows

operating_margin: Only 0 of 4 companies have a verified fact; threshold is 2.
free_cash_flow: Only 1 of 4 companies have a verified fact; threshold is 2.
capex: Only 1 of 4 companies have a verified fact; threshold is 2.

Withheld dimensions

business_model: No quote passed the evidence checks.
geographic_customer_exposure: No quote passed the evidence checks.
capital_allocation: No quote passed the evidence checks.
stated_strategy: No quote passed the evidence checks.
idiosyncratic_risks: No quote passed the evidence checks.
recent_narrative_change: No quote passed the evidence checks.

Withheld cells

JPM / business_model: no quote passed the evidence checks
BAC / business_model: no quote passed the evidence checks
C / business_model: no quote passed the evidence checks
WFC / business_model: no quote passed the evidence checks
JPM / geographic_customer_exposure: no quote passed the evidence checks
BAC / geographic_customer_exposure: no quote passed the evidence checks
C / geographic_customer_exposure: no quote passed the evidence checks
WFC / geographic_customer_exposure: no quote passed the evidence checks
JPM / capital_allocation: no quote passed the evidence checks
BAC / capital_allocation: no quote passed the evidence checks
C / capital_allocation: no quote passed the evidence checks
WFC / capital_allocation: no quote passed the evidence checks
JPM / stated_strategy: no quote passed the evidence checks
BAC / stated_strategy: no quote passed the evidence checks
C / stated_strategy: no quote passed the evidence checks
WFC / stated_strategy: no quote passed the evidence checks
JPM / idiosyncratic_risks: no quote passed the evidence checks
BAC / idiosyncratic_risks: no quote passed the evidence checks
C / idiosyncratic_risks: no quote passed the evidence checks
WFC / idiosyncratic_risks: no quote passed the evidence checks
JPM / recent_narrative_change: no quote passed the evidence checks
BAC / recent_narrative_change: no quote passed the evidence checks
C / recent_narrative_change: no quote passed the evidence checks
WFC / recent_narrative_change: no quote passed the evidence checks